Based on what I’ve seen, nursing leaders today are often navigating a perfect storm: persistent workforce shortages, rising patient acuity, and mounting administrative burden2. While these challenges are complex, one truth is increasingly clear to me—if we want to give…
Pharmacy
A federal judge has struck down North Dakota’s 340B drug pricing law, ruling it unconstitutional and permanently blocking its enforcement. U.S. District Judge Daniel Traynor found the law violated both the Supremacy Clause and the Commerce Clause by interfering with…
Pharmacy leaders say the future of the profession will not hinge on any single technology or policy change, but on whether the workforce, financial model and care delivery structure evolve fast enough to keep up. During a panel at Becker’s…
U.S. prescription drug spending increased 12.7% to $915.2 billion in 2025 and is projected to exceed $1 trillion in 2026, continuing to outpace other countries and drive healthcare costs higher, according to an April 29 report from the American Society…
For three decades, hospitals and healthcare systems in the 340B Drug Pricing Program have operated with a common purpose: serve vulnerable communities and stretch scarce federal resources while managing rising costs. But as scrutiny of the program has intensified, compliance…
Advertisement
Active drug shortages in the U.S. reached 223 in the first quarter of 2026, increasing for the second consecutive quarter, according to an April report from the American Society of Health-System Pharmacists. That upward trend comes as global supply risks…
A group of leaders from New York City-based Memorial Sloan Kettering Cancer Center, Boston-based Massachusetts General Hospital and Stanford (Calif.) University are calling for academic medical centers to rethink their well-established model of drug discovery and development to stay competitive…
Novartis CEO Vas Narasimhan, MD, said the effects of President Donald Trump’s most favored nation drug pricing policy will become more pronounced over the next 18 months, according to an April 28 report from CNBC. The policy, which ties U.S.…
The FDA’s Center for Drug Evaluation and Research has proposed withdrawing approval of Tavneos (avacopan) after determining the drug has not been shown to be effective for its approved use. The agency said new information revealed unblinded study personnel manipulated…
Pharmacy technician shortages remain one of the most persistent operational challenges facing hospitals, but leaders say the problem extends beyond wage competition. While higher pay from large retailers continues to draw talent away from health systems, pharmacy executives point to…